523 related articles for article (PubMed ID: 20338186)
21. A role for lateral hypothalamic orexin neurons in reward seeking.
Harris GC; Wimmer M; Aston-Jones G
Nature; 2005 Sep; 437(7058):556-9. PubMed ID: 16100511
[TBL] [Abstract][Full Text] [Related]
22. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
Muschamp JW; Hollander JA; Thompson JL; Voren G; Hassinger LC; Onvani S; Kamenecka TM; Borgland SL; Kenny PJ; Carlezon WA
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1648-55. PubMed ID: 24706819
[TBL] [Abstract][Full Text] [Related]
23. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.
Plaza-Zabala A; Martín-García E; de Lecea L; Maldonado R; Berrendero F
J Neurosci; 2010 Feb; 30(6):2300-10. PubMed ID: 20147556
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptides controlling energy balance: orexins and neuromedins.
Nixon JP; Kotz CM; Novak CM; Billington CJ; Teske JA
Handb Exp Pharmacol; 2012; (209):77-109. PubMed ID: 22249811
[TBL] [Abstract][Full Text] [Related]
25. Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food.
Martin-Fardon R; Cauvi G; Kerr TM; Weiss F
Addict Biol; 2018 Jan; 23(1):6-15. PubMed ID: 27558790
[TBL] [Abstract][Full Text] [Related]
26. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.
Riday TT; Fish EW; Robinson JE; Jarrett TM; McGuigan MM; Malanga CJ
Brain Res; 2012 Jan; 1431():53-61. PubMed ID: 22133306
[TBL] [Abstract][Full Text] [Related]
27. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
28. [Role of hypothalamic orexin in drug addiction].
Han J; Li YH; Bai YJ; Sui N
Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):327-30. PubMed ID: 18232303
[TBL] [Abstract][Full Text] [Related]
29. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.
Hutcheson DM; Quarta D; Halbout B; Rigal A; Valerio E; Heidbreder C
Behav Pharmacol; 2011 Apr; 22(2):173-81. PubMed ID: 21285875
[TBL] [Abstract][Full Text] [Related]
30. Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.
Yeoh JW; James MH; Adams CD; Bains JS; Sakurai T; Aston-Jones G; Graham BA; Dayas CV
Neuropharmacology; 2019 Aug; 154():22-33. PubMed ID: 30253175
[TBL] [Abstract][Full Text] [Related]
31. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats.
Moorman DE; Aston-Jones G
Alcohol; 2009 Aug; 43(5):379-86. PubMed ID: 19671464
[TBL] [Abstract][Full Text] [Related]
32. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.
Georgescu D; Zachariou V; Barrot M; Mieda M; Willie JT; Eisch AJ; Yanagisawa M; Nestler EJ; DiLeone RJ
J Neurosci; 2003 Apr; 23(8):3106-11. PubMed ID: 12716916
[TBL] [Abstract][Full Text] [Related]
34. The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin.
Inutsuka A; Yamanaka A
Nagoya J Med Sci; 2013 Feb; 75(1-2):29-36. PubMed ID: 23544265
[TBL] [Abstract][Full Text] [Related]
35. Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake.
Holtz NA; Zlebnik NE; Carroll ME
Neurosci Lett; 2012 Jul; 522(1):12-5. PubMed ID: 22668854
[TBL] [Abstract][Full Text] [Related]
36. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
Taslimi Z; Haghparast A; Hassanpour-Ezatti M; Safari MS
Behav Brain Res; 2011 Feb; 217(1):41-6. PubMed ID: 20937330
[TBL] [Abstract][Full Text] [Related]
37. A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference.
Sartor GC; Aston-Jones GS
J Neurosci; 2012 Mar; 32(13):4623-31. PubMed ID: 22457508
[TBL] [Abstract][Full Text] [Related]
38. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.
LeSage MG; Perry JL; Kotz CM; Shelley D; Corrigall WA
Psychopharmacology (Berl); 2010 Apr; 209(2):203-12. PubMed ID: 20177882
[TBL] [Abstract][Full Text] [Related]
39. The potential role of the orexin reward system in future treatments for opioid drug abuse.
Zarrabian S; Riahi E; Karimi S; Razavi Y; Haghparast A
Brain Res; 2020 Mar; 1731():146028. PubMed ID: 30476469
[TBL] [Abstract][Full Text] [Related]
40. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.
Jupp B; Krstew E; Dezsi G; Lawrence AJ
Br J Pharmacol; 2011 Feb; 162(4):880-9. PubMed ID: 20973776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
